Item 16. Form 10-K Summary

2K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

None.

SIGNA****TURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

NUCOR CORPORATION
By:/s/ Leon J. Topalian
Leon J. Topalian
President and Chief Executive Officer
Dated: February 28, 2022

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints James D. Frias and A. Rae Eagle, or either of them, his or her attorney-in-fact, with full power of substitution and resubstitution for such person in any and all capacities, to sign any amendments to this report and to file the same, with exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that either of said attorney-in-fact, or substitute or substitutes, may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.

/s/ Leon J. Topalian/s/ Norma B. Clayton
Leon J. Topalian President, Chief Executive Officer and Director (Principal Executive Officer)Norma B. Clayton Director
/s/ James D. Frias/s/ Patrick J. Dempsey
James D. Frias Chief Financial Officer, Treasurer and Executive Vice President (Principal Financial Officer)Patrick J. Dempsey Director
/s/ Michael D. Keller/s/ Christopher J. Kearney
Michael D. Keller Vice President and Corporate Controller (Principal Accounting Officer)Christopher J. Kearney Director
/s/ Laurette T. Koellner
Laurette T. Koellner Director
/s/ Joseph D. Rupp
Joseph D. Rupp Director
/s/ John H. Walker
John H. Walker Non-Executive Chairman
/s/ Nadja Y. West
Nadja Y. West Director

Dated: February 28, 2022

Previous: Item 15. Exhibits and Financial Statement Schedules